12 funding opportunities are listed in this category
American Society of Health-System Pharmacists Research and Education Foundation Student Research Award
The Student Research Award is presented annually to a pharmacy student for a published or an unpublished paper or report of a completed research project related to pharmacy practice in a hospitals and health systems. Description of Award The Student Research Award consists of a $1,500 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting, and a plaque. Eligibility Article The research should be completed and the paper prepared before June 1 of the year preceding the ASHP Midyear Clinical Meeting at which the Award is to be presented. The student should be the primary author of the nominated paper. The text should reveal (or it should be obvious) that it was derived from, or is relevant to, pharmacy practice in hospitals and health systems or should reflect a philosophy applicable to pharmacy practice in those settings. The paper or report should be in publishable format (see “Procedures for submission of manuscripts to journals published by the American Society of Health-System Pharmacists” in the January issue of the American Journal of Health-System Pharmacy for an example of appropriate format). Author At the time of preparation of the paper or report, the author shall have been a full-time student enrolled in an entry-level degree program in an ACPE-accredited college of pharmacy. The nomination should be accompanied by a letter from a faculty member certifying that the nominated paper is primarily the student's work. Selection Process A selection panel will select the highest quality paper that is most pertinent to pharmacy practice in hospitals and health systems. Selection Criteria The following criteria and point values will be used: • Originality - 20 points • Significance - 15 points • Research Methodology - 25 points • Data Analysis - 25 points • Validity of Conclusions - 15 points • Total 100 points
Sponsored by the American Society of Health-System Pharmacists Research and Education Foundation Application Deadline: June 1, 2010 The ASHP Foundation Literature Awards program annually recognizes important contributions to the literature of pharmacy practice in hospitals and health systems. Administered by the ASHP Foundation since 1971, the program is based on the concept that recognition through awards stimulates research and innovation and fosters improvement in the quality of the professional literature. American Society of Health-System Pharmacists Research and Education Foundation 7272 Wisconsin Avenue Bethesda, MD 20814 (301) 664-8612 (301) 634-5712 (fax) foundation@ashp.org www.ashpfoundation.org
Pharmacy Practice Research Award
The Pharmacy Practice Research Award is for an outstanding contribution to the biomedical literature that is relevant to pharmacy practice in hospitals and health systems. The award will be given annually to the author(s) of an important contribution of research relevant to health-system pharmacy practice published during the calendar year preceding the ASHP Midyear Clinical Meeting at which the Award is presented. This award is not intended to recognize research in drug therapy. Description of Award This award consists of a $4,000 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award presentation, and a plaque. Eligibility Article For this award, research refers to formalized testing using the scientific approach, and includes survey research, modeling, comparative studies, meta-analysis, and other types of research publications that are not research in drug therapy. Contributions to the biomedical literature eligible for the award may include published materials appearing in the primary literature (electronic or print) that are widely available. The work should reveal (or it should be obvious) that the problem studied was derived from or is applicable to pharmacy practice in hospitals and health systems. Author At the time of the completion of the research, the nominated author (or, in the case of multiple authorship, at least one of the authors who was a significant contributor to the research) shall have been a pharmacist. Selection Process A selection panel will review submitted publications and select the highest quality paper that is most pertinent to pharmacy practice in hospitals and health systems. Click on the link below for the names of selection panel members: Selection Criteria The following criteria and point values will be used: • Originality - 20 points • Significance to Hospital or Health System Practice - 15 points • Research Methodology - 25 points • Data Analysis - 25 points • Validity of Conclusions - 15 points • Total 100 points
Drug Therapy Research Award
The Drug Therapy Research Award recognizes an outstanding contribution to the biomedical literature of research involving drug efficacy and safety in humans. The award will be given annually to the author(s) of an important research article primarily concerning therapeutic efficacy and drug safety in humans published during the calendar year preceding the ASHP Midyear Clinical Meeting at which the award is presented. Examples of this research include prospective studies that evaluate clinical effects, pharmacodynamics or pharmacokinetics of drug therapy. This award is not intended to recognize research in pharmacy practice or in topics other than drug effects in humans. Description of Award This award consists of a $4,000 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award presentation, and a plaque. Eligibility Author At the time of the completion of the research, the author (or, in the case of multiple authorship, at least one of the authors who was a significant contributor to the research) shall have been a pharmacist. Article For this award, research refers to formalized testing using the scientific approach and observing the clinical effects of drugs in humans. Contributions to the pharmaceutical literature eligible for the award may include published materials appearing in the primary literature (electronic or print) that are widely available. The work should reveal (or it should be obvious) that the problem studied was derived from or is applicable to drug therapy. Selection Process A selection panel will review submitted publications and select the highest quality article that is most pertinent to drug therapy in hospitals and health systems. Click on the link below for the names of selection panel members: Selection Criteria The following criteria and point values will be used: • Originality - 20 points • Significance - 15 points • Research Methodology - 25 points • Data Analysis - 25 points • Validity of Conclusions - 15 points • Total 100 points
Award for Innovation in Pharmacy Practice
The Award for Innovation in Pharmacy Practice is for an outstanding contribution to the biomedical literature that describes an innovation in pharmacy practice in hospitals and health systems. The award will be given annually to the author(s) of the most noteworthy contribution to the literature describing an innovative pharmacy practice in hospitals and health systems published during the calendar year preceding the ASHP Midyear Clinical Meeting at which the award is presented. This award recognizes articles, other than scientific research, that contribute significantly to the betterment of the profession and describe innovations in hospital and health-system pharmacy practice that have applications beyond the practice site in which they were developed. Description of Award This award consists of a $4,000 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award presentation, and a plaque. Eligibility Article For this award, pharmacy practice refers to all aspects of professional practice in hospitals and health systems, including administrative, managerial, drug use control, technological services, clinical services, information processing, and new practice models. Contributions to the literature eligible for the award may include published materials appearing in the primary literature or books (electronic or print) that are widely available. Author At the time of the completion of the work described in the article, the nominated author (or, in the case of multiple authorship, at least one of the authors who shall have had a primary role in the literature contribution) shall be a pharmacist. Selection Process A selection panel will review submitted publications and select the highest quality paper that is most reflective of innovation in pharmacy practice in hospitals and health systems.
Selection Criteria The following criteria and point values will be used: • Statement of Problem, Conceptualization, and Execution - 25 points • Originality of the Innovation - 30 points • Significance of the Contribution to Pharmacy Practice - 25 points • Applicability of Innovation to Other Practice Sites - 20 points • Total 100 points
Award for Sustained Contributions to the Literature of Pharmacy Practice
The Award for Sustained Contributions to the Literature of Pharmacy Practice is given to an individual for publishing relevant articles of consistently high quality and importance in the biomedical literature related to hospitals and health systems over a minimum of 10 years. Emphasis is placed on the significance and impact of the nominee's contributions to the profession, rather than quantity. Ten of the candidate's best contributions to the literature related to hospitals and health systems will be evaluated in this award category. Description of Award This award consists of a $4,000 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award presentation, and a plaque. Eligibility Article Contributions to the biomedical literature eligible for the award may include published materials appearing in periodicals, books, textbooks, textbook chapters, or other publications (electronic or print) that are widely available. The nominee must have been a significant contributor or primary author of all of these publications. Author For this award, the author shall be a pharmacist. Past recipients of this award are not eligible for renomination. Selection Process The Selection Panel will review the 10 submitted publications of each nominated author and choose the individual whom they judge has made the most noteworthy contributions of highest quality to the literature of pharmacy practice in hospitals and health systems over a period of at least 10 years.
Selection Criteria The following criteria and point values will be used: • Significance to health-system practice - 20 points • Impact on profession - 35 points • Noteworthiness of contributions - 20 points • Contributions made over a sustained period - 25 points • Total 100 points
American Society for Clinical Pharmacology and Therapeutics Young Investigator Award
ASCPT is now accepting applications for the 2010 Young Investigator Award (YIA). The YIA award is intended to support a fellow or junior faculty member in clinical pharmacology or related field. The award includes a $35,000 grant. Deadline for applications is May 13, 2010.
The Young Investigator award is intended to support a fellow or junior faculty member in clinical pharmacology or related field who is engaged in clinical/translational research.
ASCPT broadly defines clinical research to be investigation in clinical pharmacology that is hypothesis-driven research that is focused on drug discovery and molecular research, drug development, drug action and disposition, clinical trials, regulatory sciences, therapeutics and outcomes research. Our focus is on human-based research.
The applicant must have completed a doctoral degree (MD, PharmD or PhD) at the time of grant award (July 2010) and be in a fellowship program focused on clinical pharmacology or must be within one year of the anniversary date of their faculty appointment.
• An application will be made by the applicant that describes the applicant, mentor, institution, and project. The ASCPT selection committee will critically evaluate these applications.• An institutional commitment for a faculty appointment at time of grant submission is not required but the applicant should be working in a laboratory or clinical research setting.• The sponsoring facility must be an academic medical institution. The primary mentor must be in the candidate’s proposed research field, must assume responsibility, and provide guidance for the research.• Applicants must provide evidence that IRB approval is pending at the time of application.• If the mentor is not an active ASCPT member, a supporting letter from an ASCPT member must beincluded.• Applicants should be planning an investigative career in clinical pharmacology.• It is expected that at the time of the award, the applicant be a member of ASCPT.• The applicant should spend at least 60-75% of his or her time in research during the award period.• Eligible candidates may submit only one application to ASCPT per year.• The Grant is for a one-year period, July 1, 2010 - June 30, 2011, for the total amount of $35,000.
Payments are made to the applicant’s institution in two equal installments on July 1 and January 1. The grantis comprised of $31,000 to support the grant project, $1,500 for travel related to the project including theASCPT Annual Meeting and $2,500 for the institution to help defray the costs related to the administration ofthe project. Disbursement of funds is contingent upon final IRB approval. If final IRB approval if not given, the award will not be granted.
• The grant funds are directed to the sponsoring institution and may provide salary support, supplies, equipment, travel, etc. necessary for pursuit of the recipient’s research project.• At the conclusion of the grant period, a final report is required highlighting the project’s progress and summarizing the usage of funds.• In accordance with the goals of the ASCPT to assist with the careers of young investigators, recipients are required to respond to ASCPT’s requests for information on their career progress following the active grant.
The Young Investigator Award information can be downloaded from the ASCPT web site at www.ascpt.org
Questions about the Young Investigator Award can be directed to:Sharon J. Swan, CAE, ASCPT Executive DirectorSharon@ascpt.org or 703.836.6981
Applications are due to ASCPT by:5:00 pm Eastern time on Thursday, May 13, 2010Applications should be sent to:ASCPT, 528 North Washington Street, Alexandria, VA 22314 USA
Award for Excellence in Medication-Use Safety
The American Society of Health-System Pharmacists (ASHP) Research and Education Foundation created the Award for Excellence in Medication-Use Safety in 2004. This is the only award program to honor a pharmacist-led multidisciplinary team for its significant institution-wide system improvements relating to medication use.The $50,000 award, which is sponsored by the Cardinal Health Foundation, recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award also honors two finalists, who each receive $10,000.
The 2010 application is now available. Applications are being accepted through April 29, 2010.EligibilityPractitioners from all hospitals and health systems within the United States are eligible to apply for the award. The practitioner’s hospital or health system must be licensed by the state(s) in which it is located. Previous winners and finalists of this award program are not eligible for the ensuing 5 years after they were recognized as a winner or finalist (e.g., 2006 winners and finalists would be eligible to apply in 2011).Selection CriteriaEach application for the awards program will be evaluated on a 5 point scale using the following four criteria: medication-use system initiative/scope, planning and implementation, measurable outcomes and impact, and innovation and applicability. Each selection criteria will be tabulated using the following scale: 1. Minimal 2. Developing 3. Achieving 4. Accomplished, and 5. Exemplary.Three applicants will be chosen as finalists for the award. The same selection criteria will be utilized during the site visit evaluations for determination of the first place winner and finalists.Medication-Use System Initiative/Scope• Scope was system-wide and broad in nature. Initiative encompassed multiple components of the medication-use system.• The issue or challenge was quantifiable. There was evidence of measurements taken to quantify the issue.• After data collection and analysis was completed, there was sufficient evidence that a performance improvement plan was necessary; the data was compelling.• Evidence of the pharmacist’s role in issue identification and leadership was apparent.Planning and Implementation• The pharmacist (or pharmacist in conjunction with others) identified and engaged multidisciplinary stakeholders.• Implementation approach-the plan was well-constructed and was based on comprehensive plans and time tables.• The initial goals for the improvements and endpoints for the improvements were identified.• The group identified barriers and developed strategies to overcome them.• Educational and communication needs of staff were identified in plan.• Evidence of pharmacist’s role in developing and implementing plan.Measurable Outcomes and Impact• Results were measurable and clearly demonstrated impact on the medication-use system and patient care in achievement of the goal.• The data collected from measurements was examined. Adequate adjustments were made after initial measurement and/or feedback if applicable.• Improved outcomes were achieved over a sustained period of time.• Results of the project have been communicated and utilized within the institution.• Unique lessons were learned and communicated.• Evidence of the pharmacist’s role in assessing results, communicating results and gauging impact.Innovation and Applicability• Innovative or effective approach(s) of achieving teamwork and cooperation across disciplines.• Ability for wide-scale adoption or implementation by other hospitals or health-systems.• Project plan, results and lessons learned communicated to others-externally.• Demonstrated an innovative approach to use of resources (i.e. dollars, staff time, techniques, tools).• Sustainability of results.
ASHP Research and Education Foundation7272 Wisconsin AvenueBethesda, Maryland 20814Phone: (301) 664-8612Fax: (301) 634-5712E-mail: foundation@ashp.orgWeb site: www.ashpfoundation.org
American Society of Health-System Pharmacists Research and Education Foundation Federal Services Junior Investigator Research Grant
Supported by AbbottApplication Deadline: April 2, 2010DescriptionThe Federal Services Junior Investigator Research Grant Program supports new investigators' research efforts critical to the study of medication adherence and persistence in older patients who receive care through the Veterans Administration, the Department of Defense, and the Public Health Service. These medication adherence and persistence studies should focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. A secondary goal of the program is to develop and strengthen the skills of newer researchers in the federal services and foster mentoring of these researchers by more experienced senior investigators.Applications for this research grant program should emphasize study objectives that focus on optimal medication outcomes, sound research methods that support the study objectives, interdisciplinary collaborations, the potential for the project to be replicated in other federal health systems, and prudent use of grant funds.Eligibility CriteriaThe research must focus on the topic area. The proposed research must be conducted in a Veterans Administration, Department of Defense, or Public Health Service facility. The principal investigator for the project must be a licensed pharmacist, physician, or nurse. The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree or postgraduate training or have professional experience greater than 5 years and no more than two externally funded research projects as a principal investigator. The senior investigator must be a licensed pharmacist, physician, or nurse. The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval or evidence of exemption from IRB review has been received. The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. The study timeline should not exceed 2 years beyond project initiation.Funding InformationTwo $25,000 grants will be awarded. Grants are awarded to junior investigators to provide funding for research related to medication adherence and persistence studies that focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease and are not intended for long-term support of research programs. One-third of the total grant will be provided with the notice of the award. One-third will be provided following receipt of a written progress report submitted at the midpoint of the timeline for study completion. The remaining one-third will be provided upon receipt of a final report that is due within 60 days of project completion.Application ProcessPharmacists, physicians, and nurses interested in applying for funding should refer to the request for proposals and application instructions when posted for full eligibility requirements and application procedures.Selection CriteriaGrant applications will be judged by a selection panel using the following criteria: • Rationale-10 points• Significance-10 points• Hypothesis/Objectives-20 points• Study Methods-40 points• Project Scope and Timeline-5 points• Personnel and Facilities-15 points
American Society of Health-System Pharmacists Student Society Development Grant Program
The ASHP Student Society Development Grant Program (formerly known as Seed Grants) is intended to encourage the development of student societies of health-system pharmacy (SSHPs) in colleges of pharmacy throughout the United States. Grants are intended for use by the ASHP state affiliate and college of pharmacy partners to establish a new SSHP, or to strengthen an existing SSHP, and ultimately to aid the SSHP to achieve official ASHP Recognition (visit www.ashp.org/students for more information on the recognition program); Grant funds available may vary each year and are intended for activities and programs to be implemented during the 2010-2011 academic year. Grant proposals should outline plans for activities and programming as specified in the criteria for the ASHP Student Society Recognition Program; Priority is given to applicants who develop a plan to establish a new SSHP in a school where one does not currently exist; Schools with existing SSHPs may also apply for funds to strengthen the organization in an effort to achieve official ASHP recognition, with preference given to newly established SSHPs (within past 36 months) and established but inactive SSHPs.
Eligibility ACPE accredited and provisionally accredited colleges of pharmacy are eligible to apply. Satellite campuses may apply for separate grants ONLY if they exist (or plan to exist) as a distinct organization from the main campus (e.g. distinct bylaws, officers, meetings, projects, etc.). Grant recipients are not eligible to receive the ASHP Student Society Development Grant in two consecutive years. Evaluation Criteria Follow the guidelines below to draft your grant proposal. Successful proposals will address specifically how the activities and programming planned will help the student society to achieve official ASHP student society recognition. (visit www.ashp.org/students to learn more about recognition program). Objective: (limit to 150 words or less) Provide a brief, clear statement of the objective of your grant proposal (e.g. Launch new SSHP; Strengthen fledgling SSHP, Achieve SSHP Recognition, Revive inactive SSHP, etc.). Activity and Programming Plans: (limit to 2-pages or less) Describe the activities and programming you intend to complete to achieve official ASHP Student Society Recognition by meeting the criteria as listed below.
Membership Describe plans to hold at least one membership drive during the academic year to recruit members for ASHP, the ASHP state affiliate (if one exists) and the SSHP
Career Development Describe plans to administer the school-level Clinical Skills Competition (visit www.ashp.org/clinicalskills to learn more. This requirement is waived for new schools without students enrolled in the final two professional years.) Describe plans to coordinate at least two (2) events featuring health-system speakers Describe plans to coordinate at least one (1) informational session on residency training
Professional Development Project Describe plans to participate in at least one (1) project to help ASHP meet the goals expressed in the ASHP Leadership Agenda
Funding: (limit to 1-page or less) Describe funds requested and how these will be utilized to achieve activity and programming plans. Describe additional fundraising plans to supplement grant monies received. (note: Up to $500 can be requested by the college of pharmacy and an additional $250 can be requested if applying jointly with the state affiliate health-system pharmacy organization for a total of $750. Joint applications should clearly describe involvement of state affiliate organization and specifically indicate how additional funds will be used. Funds will be dispersed separately as assigned to the school or state affiliate. Contact students@ashp.org if you need assistance locating the contact information for your state affiliate president and/or executive.)
Important Dates and Deadlines: All grant applications must be received on or before May 30, 2010. Applications will be evaluated and awards will be distributed on or before July 31, 2010. Grant recipients should plan to present a summary of the proposed and/or competed activities and programming to date as a poster at the 2010 ASHP Midyear Clinical Meeting Student Society Showcase (tentatively scheduled for December 5th, 2010). A final summary of completed activities and programs should be submitted to ASHP no later than May 1, 2011. Summaries will be posted to the ASHP website.
How to Apply Complete application form: 2010 ASHP Student Society Grant Program Application Form
Forward all materials in ONE submission to the address listed below. Grant proposals for 2010 must be received by May 30, 2010. Evaluation, selection and funding will be completed by July 31, 2010. E-mail (preferred): Students@ashp.org Fax: 301-634-5962 Mail: ASHP Pharmacy Student Forum 7272 Wisconsin Avenue Bethesda, MD 20814
Promoting Influenza Prevention: Pharmacists As Immunization Advocates--A Demonstration Grant Program
Supported by CSL Biotherapies Application Deadline: April 16, 2010 Each year in the United States, an estimated 20 percent of the population gets influenza. While most people recover without complications, more than 200,000 people are hospitalized and about 36,000 people die. Influenza vaccination is the most effective tool to prevent those deaths. It is estimated that only 42 percent of health care personnel in the United States receive a yearly influenza vaccination, even though healthcare worker immunization has been identified as a critical strategy in protecting patients from exposure. Description The ASHP Foundation is offering support for demonstration projects that focus on the pharmacist’s role in promoting vaccination against seasonal influenza. These demonstration projects should address implementation of programs that advance seasonal influenza immunization in healthcare workers during the 2010/2011 influenza season and should incorporate resources from ASHP’s Stop the Flu – It Starts with You resource center. Eligibility Criteria • The proposed research must involve demonstration projects focused on the pharmacist’s role in promoting vaccination against seasonal influenza. If the principal investigator does not have a strong research track record, inclusion of a senior investigator as a member of the research team is strongly advised. The principal investigator must be a licensed pharmacist and multidisciplinary research teams are strongly encouraged. If a senior investigator participates on the research team as a mentor/advisor, in the application process and grant progress reports evidence must be included regarding the support and involvement of the senior investigator. The senior investigator must have a strong research track record. The senior investigator does not have to be a pharmacist. Consideration should be given to allocating a portion of the budget to support biostatistics consultation. • The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval has been received. • Individuals who currently serve as a principal investigator or co-principal investigator on an existing ASHP Foundation-supported research grant, with the exception of new investigator grants, are not eligible for funding through this grant program. Individuals who served as principal investigators on previous ASHP Foundation grants are eligible to apply if all work, including publication of study findings, on the previously funded research is complete. If a tie score occurs during the grant review process, the grant will be awarded to the applicant(s) who has/have not received a grant from the ASHP Foundation previously. • The ASHP Foundation only makes grants to tax-exempt institutions or agencies in the United States of America. • The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research that was amended in October, 2001. • The research must comply with the NIH Policy and Guidelines On the Inclusion of Children As Participants in Research Involving Human Subjects. • The study timeline should not exceed 18 months from project initiation. Funding Information Two $25,000 grants will be awarded. Grants will be awarded to pharmacist investigators to provide funding for specific practice-based research related to the pharmacist’s role in promoting vaccination against seasonal influenza and are not intended for long-term support of research programs. Facilities and administrative cost rates that do not exceed 8% of the total requested budget are allowed. Application Process Pharmacists interested in applying for funding should refer to the request for proposals and application instructions below for full eligibility requirements and application procedures. Selection Criteria Grant applications will be judged by a selection panel using the following criteria: • Rationale-10 points • Significance-10 points • Objectives-20 points • Study Methods-40 points • Scope and Timeline-5 points • Personnel and Facilities-15 points Deadline April 16, 2010
American Society of Health-System Pharmacists Research and Education Foundation 7272 Wisconsin Avenue Bethesda, Maryland 20814 Phone: (301) 664-8612 Fax: (301) 634-5712 E-mail: foundation@ashp.org Web site: www.ashpfoundation.org
12next
